An increasing in the levels of p-Akt (S473, T308) were found after TMZ treatment in a time- and dose-dependent manner in glioblastoma cell lines, which suggests that the activation of AKT may lead to TMZ resistance (43). This evidence concerns the gene AKT1 and glioblastoma.